Literature DB >> 18783395

The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003.

Adrian R Levy1, Boris Sobolev, Douglas James, William Barrable, Penny Clarke-Richardson, Sean D Sullivan, Paul A Keown, Stephen Chung, Lyn Straatman, Robert D Levy.   

Abstract

OBJECTIVES: Solid organ transplantations are among the most expensive treatments yet relatively few investigators have reported well-characterized and reliable information on costs. The objective here was to compare the direct medical costs of kidney, liver, heart, and lung transplantations in British Columbia (BC), Canada.
METHODS: Using data from a province-wide population-based registry, resource utilization data were collated for 1333 patients who underwent solid organ transplantation between 1995 and 2003. Resource categories included hospital stays, physician fees, laboratory and diagnostic testing, and immunosuppressants. Mean costs (2003 $CDN) were derived for the index hospitalization and each of the 2 years after hospital discharge. To enable valid comparisons, the same costing methodology was applied to all four programs.
RESULTS: The mean costs of transplantation varied from $27,695 for kidney recipients to $89,942 for lung recipients, with inpatient hospital stays comprising the largest component. Mean costs for the first and second follow-up years ranged from $27,592 and $11,424 for lung recipients to $21,144 and $8086 for liver recipients. Immunosuppressants accounted for between two-thirds and three-fourths of costs by the second year. Within each program, variations in costs could not be accounted for by demographic factors.
CONCLUSIONS: We observed in BC a threefold variation in mean costs of organ transplantation procedures, with the variations between programs diminishing during follow-up. Policymakers and decision-makers seeking to better understand the deployment of resources for transplantation may focus on clinical factors at the time of hospitalization and factors that influence use and costs of immunosuppressants during the induction and maintenance phases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18783395     DOI: 10.1111/j.1524-4733.2008.00445.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  7 in total

1.  Utility and cost of a renal transplant transition clinic.

Authors:  Chanel Prestidge; Alexandra Romann; Ognjenka Djurdjev; Mina Matsuda-Abedini
Journal:  Pediatr Nephrol       Date:  2011-08-09       Impact factor: 3.714

2.  Mindfulness-based retreat for mothers of paediatric heart transplant recipients: protocol for a pilot intervention study.

Authors:  Taylor Robertson; Sara Ahola Kohut; Heather Telfer; Mirna Seifert-Hansen; Joanna Mitchell; Samantha J Anthony
Journal:  BMJ Open       Date:  2022-07-08       Impact factor: 3.006

3.  Reverse auction: a potential strategy for reduction of pharmacological therapy cost.

Authors:  Sara Michelly Gonçalves Brandão; Victor Sarli Issa; Silvia Moreira Ayub-Ferreira; Samantha Storer; Bianca Gigliotti Gonçalves; Valter Garcia Santos; Nelson Carvas Junior; Guilherme Veiga Guimarães; Edimar Alcides Bocchi
Journal:  Arq Bras Cardiol       Date:  2015-07-21       Impact factor: 2.000

4.  Facial Transplantation in a Nationalized Health System: The Canadian Experience.

Authors:  Etienne Lorquet; Alexander Govshievich; André Chollet; Dominique M Tremblay; Daniel E Borsuk
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-25

5.  Influence on ICU course, outcome and costs for lung transplantation after implementation of the new Swiss transplantation law.

Authors:  Stephanie Klinzing; Giovanna Brandi; Dimitri A Raptis; Urs Wenger; Denise Weber; Paul A Stehberger; Ilhan Inci; Markus Béchir
Journal:  Transplant Res       Date:  2014-04-01

6.  "Tremendous financial burden": Crowdfunding for organ transplantation costs in Canada.

Authors:  Sarah J Pol; Jeremy Snyder; Samantha J Anthony
Journal:  PLoS One       Date:  2019-12-20       Impact factor: 3.240

7.  An Integrated Clinical and Genetic Prediction Model for Tacrolimus Levels in Pediatric Solid Organ Transplant Recipients.

Authors:  Sandar Min; Tanya Papaz; A Nicole Lambert; Upton Allen; Patricia Birk; Tom Blydt-Hansen; Bethany J Foster; Hartmut Grasemann; Lorraine Hamiwka; Catherine Litalien; Vicky Ng; Noureddine Berka; Patricia Campbell; Claude Daniel; Chee Loong Saw; Kathryn Tinckam; Simon Urschel; Sara L Van Driest; Rulan Parekh; Seema Mital
Journal:  Transplantation       Date:  2022-03-01       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.